BioSpace News Archive

Avertix Medical, Inc. announced The Guardian System™ data was presented at the Transcatheter Cardiovascular Therapeutics conference in San Francisco.

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from two pivotal Phase 3 clinical studies evaluating trenibotulinumtoxinE (BoNT/E) for the treatment of moderate to severe glabellar lines (M21-500 and M21-508).

TerSera Therapeutics LLC announced that The National Comprehensive Cancer Network® Head and Neck Cancers Panel included a category 2B recommendation for goserelin as useful, in certain circumstances, for recurrent, unresectable, or metastatic salivary gland tumors in Version 1.2024 of the Head and Neck Cancers Guidelines released on October 9, 2023.

Medinol today announced United States Food and Drug Administration (FDA) approval for the EluNIR-PERL™ drug-eluting stent (DES) for the treatment of coronary artery disease.

Alveo Technologies, Inc. announced a collaboration with Corteva Agriscience to expand the offering of its novel eco-friendly molecular sensing and disease diagnostics technology to include a first-in-field agricultural disease diagnostic.

Biostax Corp, a leading public company specializing in healthcare solutions, announced a milestone in its transformative rebranding initiative.

BostonGene and Exigent Research , an independent community oncology research network, announced the BostonGene and Exigent Genomic INsight (BEGIN) Study, designed to demonstrate the clinical benefits of using BostonGene Tumor Portrait™ test for advanced cancer patients in a community setting.

The Lung Cancer Mutation Consortium, facilitated by the Lung Cancer Research Foundation, announces the enrollment of one hundred patients in its fourth study, LCMC4 Evaluation of Actionable Drivers in EaRly Stage Lung Cancer, examining targeted drugs given as single agents and combinations as neoadjuvant therapies matched to specific genetic mutations.

Sage Product Development, Inc., a leading medical device contract product development and early-stage manufacturing firm, is excited to announce the appointment of Laurie Bourgeois as Vice President of Business Development.

An artificial intelligence tool effectively detected distress in hospital workers’ conversations with their therapists early in the pandemic, a new study shows, suggesting a potential new technology that screens for depression and anxiety.